FTC drops AbbVie antitrust case, but fires a parting shot at the firmAbbVie will not be pursued any further by the US government over allegations that it used ‘sham’ litigation Share XFTC drops AbbVie antitrust case, but fires a parting shot at the firmhttps://pharmaphorum.com/news/ftc-drops-abbvie-antitrust-case-but-fires-a-parting-shot-at-the-firm/
FDA okays Viatris’ insulin drug as first ‘interchangeable’ biosimilarGeneric drugmaker Viatris has become the first company to secure FDA approval for a biosimilar product that is Share XFDA okays Viatris’ insulin drug as first ‘interchangeable’ biosimilarhttps://pharmaphorum.com/news/fda-okays-mylan-insulin-drug-as-first-interchangeable-biosimilar/
White House pledges $3 billion war chest for COVID antiviralsThe Biden Administration has said it will allocate $3 billion of its pandemic rescue plan to the development Share XWhite House pledges $3 billion war chest for COVID antiviralshttps://pharmaphorum.com/news/white-house-pledges-3-billion-war-chest-for-covid-antivirals/
US orders 500m Pfizer/BioNTech COVID jabs for developing nationsThe US government will buy 500 million more doses of the Pfizer/BioNTech COVID-19 vaccine that will be given Share XUS orders 500m Pfizer/BioNTech COVID jabs for developing nationshttps://pharmaphorum.com/news/us-orders-500m-pfizer-biontech/
Merck nabs $1.2 billion order for oral COVID antiviral from USThe US government has placed an order with Merck & Co to buy 1.7 million courses of its Share XMerck nabs $1.2 billion order for oral COVID antiviral from UShttps://pharmaphorum.com/news/merck-grabs-1-2-billion-order-for-oral-covid-antiviral-from-us/
Moderna will file COVID-19 jab for teens after trial shows 100% protectionModerna’s COVID-19 vaccine has joined the Pfizer/BioNTech jab in showing efficacy in younger patients in clinical trials, setting Share XModerna will file COVID-19 jab for teens after trial shows 100% protectionhttps://pharmaphorum.com/news/moderna-will-file-covid-19-jab-for-teens-after-trial-shows-100-protection/
Safety of mRNA COVID-19 jabs backed, despite myocarditis casesAs US and EU health regulators review cases of heart inflammation seen in young people administered mRNA-based COVID-19 Share XSafety of mRNA COVID-19 jabs backed, despite myocarditis caseshttps://pharmaphorum.com/news/safety-of-mrna-covid-19-jabs-backed-despite-myocarditis-cases/
Study finds Germany trails Spain and the US in digital healthGermany is lagging behind other countries in the adoption of digital health, including Spain and the US, according Share XStudy finds Germany trails Spain and the US in digital healthhttps://pharmaphorum.com/news/study-finds-germany-trails-spain-and-the-us-in-digital-health/
Update: J&J COVID vaccine rollout paused as clot concerns spreadUS health authorities have recommended pausing dosing with Johnson & Johnson’s COVID-19 vaccine as they investigate cases of Share XUpdate: J&J COVID vaccine rollout paused as clot concerns spreadhttps://pharmaphorum.com/news/us-seeks-halt-on-jj-covid-vaccine-rollout-as-clot-concerns-spread/
